Progen Industries (ASX:PGL) is trading on ASX at a large discount to the price on the US market.
In the past few weeks the volume traded in USA has increased and last night more than 1 mil. shares traded (big vol. for this stock) on NASDAQ where PGLAF closed @ US$0.83 = A$1.27. One PGLAF = one PGL.
Can't explain why PGL is trading at such a discount in OZ.
Today (11 June) Progen will be having presentations for shareholders in Brisbane and Sydney. 12 June in Melbourne.
Prof. John Zalcberg, a non-executive director, will give a presentation on PI-88 clinical development program with clinical interpretation.
My guess is that biotech investors in US are aware of the content of this presentation.
up 43% with large volume on nasdaq
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 43.5¢ | $58.28K | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 277628 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 107496 | 3 |
View Market Depth
| Last trade - 15.25pm 25/06/2024 (20 minute delay) ? |
| PGL (ASX) Chart |